// App-Quantinova.ai

e15066 : Tissue distribution and brain penetration of niraparib in tumor bearing mouse models and its clinical relevance.

Researchers

Presenter

  • Keyur Gada

Principal Investigators

  • Geeta Sharma

  • Casey Kmett

  • Elisabeth Minthorn

  • David Lugo

  • Andrew Gehman

  • Giulia Fulci

  • Amine Aziez

  • Sebastien Hazard

  • Tara L. Frenkl

  • Simon Roberts

Medical Centers

  • GlaxoSmithKline, Waltham, MA

  • GlaxoSmithKline, Collegeville, PA

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • GlaxoSmithKline,Zug,Switzerland

  • GlaxoSmithKline, Waltham, MA

Locations

  • United States

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Brain cancer

Biomarkers

  • N/A

Drug/Treatment

  • Niraparib

  • Olaparib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A